City
Epaper

Covid vaccination plan ambitious yet realistic, says DST's Dr Ashutosh Sharma

By ANI | Updated: May 31, 2021 11:15 IST

The Centre's COVID-19 vaccination plan to innoculate all citizens of the country by December 31 is not only ambitious but also realistic, said Dr Ashutosh Sharma, Secretary, Department of Science and Technology.

Open in App

The Centre's COVID-19 vaccination plan to innoculate all citizens of the country by December 31 is not only ambitious but also realistic, said Dr Ashutosh Sharma, Secretary, Department of Science and Technology.

"In terms of technology, we are totally prepared for the third wave and would get even better as we go forward this year. Our vaccination plan to innoculate all citizens of the country by December is not only ambitious but also realistic," Dr Sharma toldon Sunday.

"During the first wave, we built a huge infrastructure which was related to basic things like ventilator, all kinds of diagnostics, PPE kits, N-95 masks, now we even have a vaccine which is of Indian origin. In addition to setting up the infrastructure for vaccine, cold chain, the supply lines, logistics, all have been put together quickly in the first wave," Dr Sharma said.

He added, "the second wave was rather sudden and we found that certain things were missing and that was not as much available in quantity as was needed at the peak of the second wave."

Speaking about the innovation related to oxygen supply, he said many innovations have been done related to the oxygen supply like repurposing many oxygen plants where plants that were producing industrial oxygen have been repurposed for the medical oxygen.

As India battles the second wave of the coronavirus pandemic science-based start-ups and innovations are playing a crucial role.

Speaking on innovation related to RT-PCR testing, the doctor said that new RT-PCR from Sree Chitra Tirunal Institute for Medical Sciences and Technology targets two genes, one of which does not undergo many mutations. "So, we will not produce false RT-PCR readings as much as otherwise might happen."

"An antibody kit has been developed at Indian Institute of Science, Bangalore. lt looks at antibodies IgM and IgG. The kit measures the quantity of antibodies. It also determines if they are fading." Dr Sharma added.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: indiabangaloreSree Chitra Tirunal Institute For Medical Sciences And TechnologyDepartment of science and technologyNodal departmentIndiUk-indiaScience and innovation blade nzimandeRepublic of indiaDepartment of science and technology of india
Open in App

Related Stories

Maharashtra"This is Betrayal": Former MP Calls Out Prada for Allegedly Copying Kolhapuri Chappal Design

InternationalWhen Will Russia Deliver More S-400 Missiles to India? Major Update Revealed - Here’s Why It Was Delayed

NationalIndia Extends Airspace Ban on Pakistan-Based Aircraft Till July 24

Social Viral‘Eiffel Tower of Bengaluru’: Internet Mocks Dangerous Electric Pole in the Middle of the Road

NationalOperation Sindhu: “We Saw Drones, Missiles,” Say Evacuated Students Recounting Life in Iran’s Warzone

National Realted Stories

NationalOne dead after iron shed collapses at plastic factory in Gujarat

NationalTripura govt to set up medical hub to offer best healthcare to patients, says CM Saha

National14-year-old girl found unconscious with multiple wounds in moving train in MP

NationalPM Modi-Nitish Kumar posters in Patna spark political buzz ahead of Bihar polls

NationalFirst time in 25 years, BJP re-elects sitting Uttarakhand unit chief Mahendra Bhatt